Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PTAG Activators

The chemical class designated as PTAG activators encompasses a diverse range of compounds that share the common capability of upregulating or modulating the activity of the protein PTAG. These activators exert their influence through various cellular mechanisms and pathways, ultimately leading to an increase in the expression or functional activity of PTAG. The biochemical interactions that facilitate the activation of PTAG are generally centered on the modulation of cellular stress responses, particularly those involving the endoplasmic reticulum (ER), where PTAG is thought to play a significant role. By inducing ER stress, certain chemicals initiate a cascade of events that elevate the unfolded protein response (UPR), a cellular defense mechanism. This response, in turn, can lead to an upsurge in the expression of proteins associated with the ER-associated degradation (ERAD) pathway, which is closely linked to the functionality of PTAG.

In addition to ER stress, these activators also target various signaling pathways that are critical for maintaining cellular homeostasis and responding to environmental cues. By inhibiting or modulating kinases involved in the MAPK pathway, for instance, these chemicals can alter the expression of a myriad of proteins, including PTAG. The precise modulation of gene expression is another avenue through which PTAG activity can be influenced. Epigenetic modulators that alter DNA methylation and histone acetylation patterns can have a profound impact on the transcriptional landscape of a cell, leading to changes in the levels of specific proteins. Proteasome inhibitors that prevent the degradation of misfolded proteins also indirectly contribute to the regulation of PTAG, as they can cause an accumulation of proteins within the ER, thereby triggering stress responses that may enhance PTAG expression. Collectively, the chemicals classified as PTAG activators function through a synergistic effect on multiple cellular processes, ensuring the fine-tuning of PTAG activity in response to the intricate needs of the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a SERCA pump inhibitor that induces ER stress and the unfolded protein response (UPR), which could activate PTAG by upregulating ERAD-related proteins.

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$34.00
$104.00
87
(2)

Salubrinal is a phosphatase inhibitor that increases the phosphorylation of eIF2α, enhancing the ER stress response and could activate PTAG expression as part of the UPR.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor; by altering MAPK signaling, it could activate PTAG expression involved in this pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, and modulation of JNK activity could activate PTAG if it plays a role in apoptotic signaling.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, 5-Azacytidine could activate PTAG by causing demethylation of its gene promoter, affecting expression patterns.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is an HDAC inhibitor that could activate PTAG by leading to changes in chromatin structure and gene expression.

4-Hydroxyphenylretinamide

65646-68-6sc-200900
sc-200900A
5 mg
25 mg
$104.00
$315.00
(0)

Fenretinide induces ER stress and UPR, which could activate PTAG by increasing the expression of proteins involved in ERAD.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could activate PTAG by influencing various cellular responses that might impact the expression of RHBDD3.